FinTech Australia has announced the finalists for Australia’s most prestigious annual fintech business awards, The Finnies. 

The technology, trusted by thousands of healthcare professionals, offers a consistent, efficient pain assessment process, streamlines record-keeping, and has expanded into home care, demonstrating its effectiveness in managing pain for individuals with dementia, disabilities, and infants.

The company also highlighted progress in its therapeutic development programs, including advancing MAP 315 for Phase II in its Inflammatory Bowel Disease Program and expanding its dataset in the Immuno-Oncology Program, alongside completing 70% of Stage 2 functional screening in its Autoimmune Disease Program.

The company also highlighted a strong demand for its ABS transactions, operational efficiencies leading to reduced funding costs, and an improvement in credit performance, setting a positive outlook for FY25.

The company, specializing in solar-powered security, surveillance, and AI solutions, aims to continue its growth and innovation in hardware and cloud-based systems across various industries.

The company also achieved a reduction in net cash used and operational costs while expanding its electric vehicle offerings and corporate demand, maintaining a healthy cash balance and expecting continued growth.